Halozyme Therapeutics Stock Jumps After Earnings, Bull Note

A short squeeze could push HALO even higher

Managing Editor
Feb 21, 2018 at 10:30 AM
facebook twitter linkedin


Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock is up 3.1% to trade at $19.11 this morning, after Canaccord Genuity upped its price target on the oncology specialist to $21 from $19. The analyst in coverage is encouraged by last night's fourth-quarter and full-year results, which showed progress in HALO's ENHANZE portfolio. 

HALO stock rode a mid-September bull gap past former resistance near the $15 level, and climbed to a two-year high of $21.13 on Dec. 29. The equity pulled back from here, due in part to a bearish note from Deutsche Bank. And while the shares eventually bounced from their rising 180-day moving average, they are still down 5.9% in 2018.

Despite today's bullish brokerage note, analyst attention has been mixed. While five brokerages covering HALO rate it a "strong buy," the other four maintain a "hold" or "sell." The average 12-month price target of $21.91, meanwhile, represents expected upside of 15.2% to the stock's current perch.

Short sellers have been in cover mode since these bearish bets topped out at a record high of 25.30 million shares last March. In the most recent reporting period alone, short interest plunged 12.05% to 10.23 million shares, though this still represents 6.4 times HALO stock's average daily pace of trading.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners